January 28, 2026

When Crisis Calls Go Unanswered

Behind the promise of 988, response breakdowns reveal risks for patients in acute distress.

KFF Health News

January 27, 2026

The Exam Room Is Listening Now

As AI quietly enters exam rooms, physicians report real relief—and real concerns about accuracy, trust, and control.

KFF Health News

January 14, 2026

What Will Redefine Pathology in 2026?

Industry leaders outline how computational modeling and large-scale sequencing will reshape discovery, diagnostics, and clinical development in 2026 and beyond

The Pathologist

January 14, 2026

Why Europe’s CDMO Sector Must Learn to Dance with Disruption

For CDMOs, the storms of de-industrialization, Brexit, and the Biosecure Act are not existential threats but the very winds that can propel them forward.

The Medicine Maker

January 09, 2026

The Xennial Pathologist in a Time of Change

Kamran Mirza on the strengths of being molded by two technological eras

The Pathologist

January 08, 2026

A Turning Point in MASH

A billion-dollar acquisition, breakthrough clinical data, and a shifting scientific paradigm are pushing MASH out of the shadows and into a new era of metabolic medicine.

The Medicine Maker

January 07, 2026

Inside 2026: The Industry’s AI Turning Point

The life sciences sector is bracing for a year when AI delivers real returns, regulators move faster, and trial operations are finally built for modern science.

The Medicine Maker

January 06, 2026

Tomorrow’s Science Leaders Roundtable: Part Two

Isabelle Kohler, Charlotta Turner, and Lourdes Ramos discuss AI, success, and redefining impact in an age of change

The Analytical Scientist

December 30, 2025

Mendelian Randomization: A Powerful Tool — When Used Properly

New TVST editorial examines the promises and Pitfalls of MR in ophthalmology

The Ophthalmologist